News

Cryo-EM allows scientists to see with higher resolution than ever before a host of biological processes and conditions, including DNA repair, cancer and infectious disease.

The College of Natural Sciences is currently celebrating Discovery Education Week to promote and discuss science education throughout the college.

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

What do you do when the bacteria you study that's deadly in the real world acts all mild and gentle in the lab?

UT Austin scientists are doing research, which uses novel single-molecule imaging techniques partially developed by Finkelstein, and could lead to a better understanding of how cancerous cells repair their DNA.

A Cancer Prevention and Research Institute of Texas award will underwrite the hire of a leading cancer researcher to serve as chair of the Department of Molecular Biosciences.

A research team led by Lauren Ehrlich of the Department of Molecular Biosciences has discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.

A research center at The University of Texas at Austin will be renamed for Dr. John Ring LaMontagne, a scientist who combated infectious diseases to improve public health around the globe.

Jonathan Sessler of the Department of Chemistry and George Georgiou of the Department of Molecular Biosciences at The University of Texas at Austin have been named Fellows of the National Academy of Inventors (NAI).

In a discovery from the lab of Jessie Zhang that holds promise for future drug development, scientists have detected for the first time how nature performs an impressive trick to produce key chemicals similar to those in drugs that fight malaria, bacterial infections and cancer.